Empowering Caregivers in ADHD Treatment: Standard Care Vs. Decision Aid, Coaching, and AI Support
Launched by ARIEL UNIVERSITY · Feb 13, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This randomized controlled trial (RCT) aims to evaluate the effectiveness of different decision-support interventions in helping parents of children with ADHD make informed treatment decisions. The study will assess the impact of structured decision aids, decision coaching, and AI-driven support on parental decision-making quality, decisional conflict, self-efficacy, knowledge, and treatment adherence. Participants will be randomly assigned to one of four study arms: standard care, a written decision aid, decision aid plus decision coaching, or AI-driven support. Outcomes will be measured a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parents or legal guardians of children aged 6-17 diagnosed with ADHD.
- • Able to provide informed consent.
- • Willing to participate in all study activities, including follow-up assessments.
- Exclusion Criteria:
- • Non-Hebrew-speaking parents (due to the language-based intervention materials).
- • Parents who have previously participated in ADHD decision aid trials.
- • Parent of children with severe comorbid psychiatric conditions requiring urgent psychiatric care
About Ariel University
Ariel University is a leading academic institution in Israel dedicated to advancing research and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, Ariel University is committed to conducting rigorous scientific investigations that aim to improve patient outcomes and contribute to the broader understanding of medical interventions. The university fosters a collaborative environment, engaging with researchers, healthcare professionals, and industry partners to develop and implement cutting-edge clinical trials that adhere to the highest ethical and regulatory standards. Through its initiatives, Ariel University strives to enhance the quality of healthcare and promote evidence-based practices in clinical settings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ariel, , Israel
Patients applied
Trial Officials
Yulia Gendler, PhD
Principal Investigator
'MyHealthAid' research lab - Ariel University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported